Trial Parameters
Condition Neurodevelopmental Disorders
Sponsor Richard Frye
Study Type OBSERVATIONAL
Phase N/A
Enrollment 1,000
Sex ALL
Min Age N/A
Max Age N/A
Start Date 2024-02-01
Completion 2030-12-31
Brief Summary
The purpose of this study is to systematically evaluate the results of medical investigations to identify symptom and biological patterns and common etiologies of neurodevelopmental disorders.
Eligibility Criteria
Inclusion Criteria: Neurodevelopmental delays Clinical visit at an Rossignol Medical Center Exclusion Criteria: \-
Related Trials
NCT06086951
Pai.ACT - An Artificial Intelligence Driven Chatbot Assisted ACT
View Trial →
NCT05681923
Platform for the Prospective Mother-child Study of the Determinants of Neurodevelopmental Disorders
View Trial →
NCT05584059
Pai.ACT Programme for Parents of Children With Special Healthcare Needs - Phase I
View Trial →